Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Recommendations for optimal ICD codes to study neurologic conditions: A systematic review.
FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod)
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.
A Friend in Need May Not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases.
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
Microtubule-stabilizing agents delay the onset of EAE through inhibition of migration.
Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.
[New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimode].
[Progressive multifocal leukoencephalopathy (review)].
Autonomic dysfunction in multiple sclerosis.
Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report.
PDE4B as a microglia target to reduce neuroinflammation.
Risk factors for idiopathic optic neuritis recurrence.
Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis.
Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.
The specific antigen approach in multiple sclerosis: Can it ever be enough?
Do Bugs Control Our Fate? The Influence of the Microbiome on Autoimmunity.
Infusion of Sulfosuccinimidyl-4-[N-maleimidomethyl]cyclohexane-1-carboxylate-Conjugated MOG35-55-Coupled Spleen Cells Effectively Prevents and Reverses Experimental Autoimmune Encephalomyelitis in Mice.
[Neuropathology of multiple sclerosis].
Early onset (childhood) monogenic neuropathies.
Fibrinogen: A Circulating Factor in Search for Its Genetic Architecture.
5-HT2 RECEPTORS FACILITATE JC POLYOMAVIRUS ENTRY.
Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
Pages
« first
‹ previous
…
300
301
302
303
304
305
306
307
308
…
next ›
last »